High-risk Aggressive Lymphoma

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-03
Clinical Trial Update: Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating maintenance therapy after autologous stem cell transplant in high-risk aggressive lymphoma.